Sort   by:  
 Page size 
UnknownP14.58 Extending adjuvant temozolomide longer than six cycles doesn’t add any benefit to glioblastoma patients according to the randomized GEINO-014 TRIAL
Not available
S-EPMC6795970 | biostudies-literature
UnknownVitamin D-regulated miRNA expression in tumoral and normal adjacent tissue of localized gastric cancer patients: the impact on survival and time to relapse.
Not available
S-EPMC12268756 | biostudies-literature
UnknownMonitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer.
Not available
S-EPMC9107427 | biostudies-literature
UnknownExpert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer.
Not available
S-EPMC10514135 | biostudies-literature
UnknownPrediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data.
Not available
S-EPMC8275736 | biostudies-literature
UnknownClinicopathological Profiles Associated with Discordant RAS Mutational Status between Liquid and Tissue Biopsies in a Real-World Cohort of Metastatic Colorectal Cancer.
Not available
S-EPMC10377339 | biostudies-literature
UnknownA phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01).
Not available
S-EPMC7746946 | biostudies-literature
UnknownTinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design.
Not available
S-EPMC12621363 | biostudies-literature
UnknownDynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
Not available
S-EPMC10912758 | biostudies-literature
UnknownEvaluation of SINERGIAPS, an intervention to improve patient safety in primary healthcare centers in Spain based on patients' perceptions and experiences: a protocol for a hybrid type I randomized clinical trial.
Not available
S-EPMC11003190 | biostudies-literature
Sort   by:  
 Page size